Production (Stage)
Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 107.50K | 5.80K | 49.80K | 76.70K | 52.50K |
Total Receivables | -- | -- | 7.90K | 56.40K | 56.40K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 11.30K | 11.30K | 15.00K | 29.80K | 33.10K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 118.80K | 17.10K | 72.70K | 162.90K | 142.00K |
|
|||||
Total Current Assets | 118.80K | 17.10K | 72.70K | 162.90K | 142.00K |
Net Property, Plant & Equipment | 1.00K | 1.30K | 1.60K | 1.80K | 2.10K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 1.70K | 1.70K | 1.70K | 3.38M | 3.38M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | 310.00K | 310.00K |
Total Assets | 121.50K | 20.10K | 76.00K | 3.86M | 3.84M |
|
|||||
Total Accounts Payable | 354.60K | 357.30K | 349.30K | 305.90K | 317.80K |
Total Accrued Expenses | 286.10K | 269.10K | 1.18M | 646.60K | 697.70K |
Short-term Debt | 50.00K | 50.00K | 10.00K | 10.00K | 10.00K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 2.21M | 1.98M | 1.75M | 1.53M | 1.31M |
Total Other Current Liabilities | 2.21M | 1.98M | 1.75M | 1.53M | 1.31M |
Total Current Liabilities | 2.90M | 2.66M | 3.29M | 2.49M | 2.34M |
|
|||||
Total Current Liabilities | 2.90M | 2.66M | 3.29M | 2.49M | 2.34M |
Long-Term Debt | 555.10K | 414.60K | 219.00K | 110.80K | 22.40K |
Short-term Debt | 50.00K | 50.00K | 10.00K | 10.00K | 10.00K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.46M | 3.07M | 3.51M | 2.60M | 2.36M |
|
|||||
Common Stock & APIC | 56.23M | 55.99M | 55.19M | 55.19M | 54.90M |
Retained Earnings | -59.57M | -59.05M | -58.63M | -53.95M | -53.43M |
Treasury Stock & Other | -- | -- | -- | 0.00 | -- |
Total Common Equity | -3.35M | -3.06M | -3.44M | 1.24M | 1.47M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 8.10K | 8.10K | 8.10K | 8.10K | 8.10K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 8.10K | 8.10K | 8.10K | 8.10K | 8.10K |
|
|||||
Total Common Equity | -3.35M | -3.06M | -3.44M | 1.24M | 1.47M |
Total Preferred Equity | 8.10K | 8.10K | 8.10K | 8.10K | 8.10K |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -3.34M | -3.05M | -3.43M | 1.25M | 1.48M |
|